Episode 52: Clinical Conversations: STEP, The First of Many Steps Toward the Future of Obesity Pharmacotherapy

Obesity: A Disease

Inhoud geleverd door Obesity Medicine. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Obesity Medicine of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

2y ago 24:44

MP3•Thuis aflevering

Gearchiveerde serie ("Inactieve feed" status)

When? This feed was archived on August 29, 2022 01:07 (1+ y ago). Last successful fetch was on July 09, 2022 08:32 (2y ago)

Why? Inactieve feed status. Onze servers konden geen geldige podcast feed ononderbroken ophalen.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this episode, obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Robert Kushner, highlighted speaker from the Overcoming Obesity 2021 Conference, about The Semaglutide Treatment Effect in People with Obesity (STEP) Trials. Topics covered include the results of the four STEP trails, obstacles to treating obesity, new obesity treatments in the pipeline, and the opportunities for increasing obesity education for future clinicians.

You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.

Episode Guest

Nicholas Pennings, DO, FOMA, Dipl. ABOM

Robert Kushner, MD

Resources Mentioned

2 0 2 1 Fall Obesity Summit

71 afleveringen

#Fitness #Medicine #Obesity A Disease